iCARDIO Alliance releases global guidelines for obesity and cardiometabolic disease management, emphasizing resource-adapted prevention and treatment

The global prevalence of obesity and associated cardiometabolic diseases (CMDs) represents a significant public health challenge, demanding comprehensive and globally applicable management strategies. Existing clinical practice guidelines often lack universal applicability, particularly in regions with varying resource availability. There is a critical gap for guidelines that not only synthesize the latest evidence but also provide practical recommendations tailored to different economic contexts. The iCARDIO Alliance aims to bridge this gap by developing implementation guidelines that improve the quality of cardiovascular care, from prevention and diagnosis to treatment and follow-up, across all economic levels.

The iCARDIO Alliance developed its 2025 global implementation guidelines for obesity and cardiometabolic disease management through an innovative, globally representative process. Writing panels comprised world-renowned experts, with a minimum of 50% representation from outside Europe and North America, ensuring diverse perspectives. A key aspect of the methodology was the explicit consideration of resource availability across three distinct economic levels: 'no economic consideration', 'resources somewhat limited', and 'resources severely limited'. The guidelines underwent a rigorous peer review by global experts, followed by a public review process, allowing for the integration of viewpoints from individuals with lived experience to enhance practical utility.

The iCARDIO Alliance's guideline development process itself represents a significant advancement in global health policy, yielding a framework designed for broad applicability. The core 'finding' is the successful establishment of a methodology that ensures global representation and resource-stratified recommendations. > The guidelines uniquely integrate resource availability into their recommendations, providing actionable advice for settings ranging from well-resourced to severely limited, a critical feature for global implementation. This approach ensures that recommendations for obesity and cardiometabolic disease management are not only evidence-based but also practically feasible across diverse healthcare systems. The inclusion of a public review phase further embeds patient perspectives, enhancing the relevance and adherence potential of the final recommendations. All guideline documents are published open access in multiple journals, maximizing dissemination and impact.